Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 11,129 | 14,511 | 17,581 | 17,070 | 14,900 |
| Cost of Goods | 8,255 | 9,709 | 10,114 | 9,550 | 8,240 |
| Gross Profit | 2,874 | 4,802 | 7,467 | 7,520 | 6,650 |
| Operating Expenses | 21,050 | 20,767 | 16,302 | 11,190 | 10,060 |
| Operating Income | -17,921 | -15,256 | -8,721 | -3,120 | -3,160 |
| Interest Expense | 1,863 | 1,516 | 1,336 | 0 | 0 |
| Other Income | 2,571 | 2,242 | 1,179 | 680 | 3,800 |
| Pre-tax Income | -17,213 | -14,530 | -8,878 | -2,440 | 640 |
| Income Tax | N/A | N/A | N/A | 70 | 0 |
| Net Income Continuous | -17,213 | -14,530 | -8,878 | -2,522 | 645 |
| Net Income | $-17,213 | $-14,530 | $-8,878 | $-2,520 | $640 |
| EPS Basic Total Ops | -6.80 | -5.80 | -4.50 | -0.70 | 0.20 |
| EPS Basic Continuous Ops | -6.78 | -5.79 | -4.55 | -0.70 | 0.18 |
| EPS Diluted Total Ops | -6.80 | -5.80 | -4.50 | -0.70 | 0.20 |
| EPS Diluted Continuous Ops | -6.78 | -5.79 | -4.55 | -0.70 | 0.17 |
| EBITDA(a) | $-15,488 | $-13,007 | $-6,679 | $-1,290 | $-1,750 |